Literature DB >> 27019039

Pathophysiologic Mechanisms of Cerebral Ischemia and Diffusion Hypoxia in Traumatic Brain Injury.

Tonny V Veenith1, Eleanor L Carter2, Thomas Geeraerts3, Julia Grossac3, Virginia F J Newcombe2, Joanne Outtrim2, Gloria S Gee4, Victoria Lupson4, Rob Smith4, Franklin I Aigbirhio4, Tim D Fryer4, Young T Hong4, David K Menon2, Jonathan P Coles2.   

Abstract

IMPORTANCE: Combined oxygen 15-labeled positron emission tomography (15O PET) and brain tissue oximetry have demonstrated increased oxygen diffusion gradients in hypoxic regions after traumatic brain injury (TBI). These data are consistent with microvascular ischemia and are supported by pathologic studies showing widespread microvascular collapse, perivascular edema, and microthrombosis associated with selective neuronal loss. Fluorine 18-labeled fluoromisonidazole ([18F]FMISO), a PET tracer that undergoes irreversible selective bioreduction within hypoxic cells, could confirm these findings.
OBJECTIVE: To combine [18F]FMISO and 15O PET to demonstrate the relative burden, distribution, and physiologic signatures of conventional macrovascular and microvascular ischemia in early TBI. DESIGN, SETTING, AND PARTICIPANTS: This case-control study included 10 patients who underwent [18F]FMISO and 15O PET within 1 to 8 days of severe or moderate TBI. Two cohorts of 10 healthy volunteers underwent [18F]FMISO or 15O PET. The study was performed at the Wolfson Brain Imaging Centre of Addenbrooke's Hospital. Cerebral blood flow, cerebral blood volume, cerebral oxygen metabolism (CMRO2), oxygen extraction fraction, and brain tissue oximetry were measured in patients during [18F]FMISO and 15O PET imaging. Similar data were obtained from control cohorts. Data were collected from November 23, 2007, to May 22, 2012, and analyzed from December 3, 2012, to January 6, 2016. MAIN OUTCOMES AND MEASURES: Estimated ischemic brain volume (IBV) and hypoxic brain volume (HBV) and a comparison of their spatial distribution and physiologic signatures.
RESULTS: The 10 patients with TBI (9 men and 1 woman) had a median age of 59 (range, 30-68) years; the 2 control cohorts (8 men and 2 women each) had median ages of 53 (range, 41-76) and 45 (range, 29-59) years. Compared with controls, patients with TBI had a higher median IBV (56 [range, 9-281] vs 1 [range, 0-11] mL; P < .001) and a higher median HBV (29 [range, 0-106] vs 9 [range, 1-24] mL; P = .02). Although both pathophysiologic tissue classes were present within injured and normal appearing brains, their spatial distributions were poorly matched. When compared with tissue within the IBV compartment, the HBV compartment showed similar median cerebral blood flow (17 [range, 11-40] vs 14 [range, 6-22] mL/100 mL/min), cerebral blood volume (2.4 [range, 1.6- 4.2] vs 3.9 [range, 3.4-4.8] mL/100 mL), and CMRO2 (44 [range, 27-67] vs 71 [range, 34-88] μmol/100 mL/min) but a lower oxygen extraction fraction (38% [range, 29%-50%] vs 89% [range, 75%-100%]; P < .001), and more frequently showed CMRO2 values consistent with irreversible injury. Comparison with brain tissue oximetry monitoring suggested that the threshold for increased [18F]FMISO trapping is probably 15 mm Hg or lower. CONCLUSIONS AND RELEVANCE: Tissue hypoxia after TBI is not confined to regions with structural abnormality and can occur in the absence of conventional macrovascular ischemia. This physiologic signature is consistent with microvascular ischemia and is a target for novel neuroprotective strategies.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27019039     DOI: 10.1001/jamaneurol.2016.0091

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


  39 in total

Review 1.  Impact of dietary polyphenols on neuroinflammation-associated disorders.

Authors:  Neeraja Revi; Aravind Kumar Rengan
Journal:  Neurol Sci       Date:  2021-05-14       Impact factor: 3.307

2.  Ischemic Brain Injury Leads to Brain Edema via Hyperthermia-Induced TRPV4 Activation.

Authors:  Yutaka Hoshi; Kohki Okabe; Koji Shibasaki; Takashi Funatsu; Norio Matsuki; Yuji Ikegaya; Ryuta Koyama
Journal:  J Neurosci       Date:  2018-05-23       Impact factor: 6.167

3.  Up-regulation of Wnt/β-catenin expression is accompanied with vascular repair after traumatic brain injury.

Authors:  Arjang Salehi; Amandine Jullienne; Mohsen Baghchechi; Mary Hamer; Mark Walsworth; Virginia Donovan; Jiping Tang; John H Zhang; William J Pearce; Andre Obenaus
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-21       Impact factor: 6.200

4.  Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, "M-type") K+ currents in neurons.

Authors:  Fabio A Vigil; Eda Bozdemir; Vladislav Bugay; Sang H Chun; MaryAnn Hobbs; Isamar Sanchez; Shayne D Hastings; Rafael J Veraza; Deborah M Holstein; Shane M Sprague; Chase M Carver; Jose E Cavazos; Robert Brenner; James D Lechleiter; Mark S Shapiro
Journal:  J Cereb Blood Flow Metab       Date:  2019-07-04       Impact factor: 6.200

Review 5.  Infliximab Can Improve Traumatic Brain Injury by Suppressing the Tumor Necrosis Factor Alpha Pathway.

Authors:  Yiru Zhou; Ruihua Fan; Benson O A Botchway; Yong Zhang; Xuehong Liu
Journal:  Mol Neurobiol       Date:  2021-01-27       Impact factor: 5.590

Review 6.  Differential expression of non-coding RNAs and association with cerebral ischemic vascular disorders; diagnostic and therapeutic opportunities.

Authors:  Sharif Alhajlah
Journal:  Genes Genomics       Date:  2022-07-08       Impact factor: 1.839

Review 7.  Multimodal Neurologic Monitoring in Children With Acute Brain Injury.

Authors:  Jennifer C Laws; Lori C Jordan; Lindsay M Pagano; John C Wellons; Michael S Wolf
Journal:  Pediatr Neurol       Date:  2022-02-02       Impact factor: 3.372

8.  Brain Oxygen Optimization in Severe Traumatic Brain Injury Phase-II: A Phase II Randomized Trial.

Authors:  David O Okonkwo; Lori A Shutter; Carol Moore; Nancy R Temkin; Ava M Puccio; Christopher J Madden; Norberto Andaluz; Randall M Chesnut; M Ross Bullock; Gerald A Grant; John McGregor; Michael Weaver; Jack Jallo; Peter D LeRoux; Dick Moberg; Jason Barber; Christos Lazaridis; Ramon R Diaz-Arrastia
Journal:  Crit Care Med       Date:  2017-11       Impact factor: 7.598

9.  Intracranial Pressure Threshold Heuristics in Traumatic Brain Injury: One, None, Many!

Authors:  Christos Lazaridis; Masoom Desai; George Damoulakis; Frederick A Zeiler
Journal:  Neurocrit Care       Date:  2020-06       Impact factor: 3.210

10.  Individualized Brain Tissue Oxygen-Monitoring Probe Placement Helps to Guide Therapy and Optimizes Outcome in Neurocritical Care.

Authors:  Levin Häni; Mario D Ropelato; Franca Wagner; Andreas Nowacki; Nicole Söll; Matthias Haenggi; Andreas Raabe; Werner J Z'Graggen
Journal:  Neurocrit Care       Date:  2020-12-16       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.